DeVore Susan D.

SEC source: 0001587697-26-000011 · wk-form4_1780003091.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,785

F1 · shares: All are restricted stock units ("RSUs") vesting on the earlier of May 26, 2027, or the date of Unum Group's next annual meeting of shareholders.

F2 · balance_after: Includes 2,191 RSUs and 29,594 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 5,540.000 RSUs since the date of the reporting person's prior Form 4.

SEC source: 0001587697-26-000008 · wk-form4_1779140330.xml · derivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,300

Underlying: Common Stock · 3,300 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

F2 · derivative.expiration_date: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

SEC source: 0001587697-26-000006 · wk-form4_1778875890.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,065

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001587697-26-000004 · wk-form4_1777667220.xml · derivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,403 shares

Expires 2035-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs are fully vested.

SEC source: 0001587697-26-000004 · wk-form4_1777667220.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,947

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001587697-26-000002 · wk-form4_1774914220.xml · derivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,980 shares

Expires 2034-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs are fully vested.

SEC source: 0001587697-26-000002 · wk-form4_1774914220.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001587697-25-000007 · wk-form4_1755807634.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,502

F1 · price: This transaction was executed in multiple purchases at prices ranging from $312.06 to $312.19. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000005513-25-000094 · wk-form4_1748045837.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,594

F1 · shares: All are restricted stock units ("RSUs") vesting on May 22, 2026.

F2 · balance_after: Includes 5,540 RSUs and 24,054 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

SEC source: 0001156039-25-000085 · wk-form4_1747426507.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,302

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001628280-25-025961 · wk-form4_1747340551.xml · derivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,564 shares

Expires 2034-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs fully vested on May 13, 2025.

SEC source: 0001628280-25-025961 · wk-form4_1747340551.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-021882 · wk-form4_1746217910.xml · derivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,403

Underlying: Common Stock · 3,403 shares

Expires 2035-04-30

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest on April 30, 2026, subject to continued service through the vesting date.

SEC source: 0000005513-25-000035 · wk-form4_1741129407.xml · nonDerivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,396

F4 · price: Reflects the weighted average price for multiple sale transactions ranging in price from $81.00 per share to $81.35 per share, inclusive.

F5 · balance_after: Includes 3,342 stock-settled RSUs and 24,054 shares of common stock. Fractional amounts have been rounded to the nearest whole number.

SEC source: 0000005513-25-000035 · wk-form4_1741129407.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,819

F1 · price: Reflects the weighted average price for multiple sale transactions ranging in price from $80.34 per share to $80.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4.

F2 · balance_after: Includes 3,342 restricted stock units and 28,477 shares of common stock. All restricted stock units ("stock-settled RSUs") may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 3,839.000 RSUs since the date of the reporting person's prior Form 4.

SEC source: 0000005513-24-000111 · wk-form4_1716934069.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,396

F1 · shares: All are restricted stock units ("RSUs") vesting on May 23, 2025.

F2 · balance_after: Includes 7,181 RSUs and 30,215 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 4,448.000 RSUs since the date of the reporting person's prior Form 4.

SEC source: 0001156039-24-000081 · wk-form4_1715977201.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,701

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001127602-24-015488 · form4.xml · derivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,544

Underlying: Common Stock · 1,980 shares

Expires 2034-05-13

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F3 · derivative.exercise_date: The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date.

SEC source: 0001127602-24-015488 · form4.xml · derivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,564

Underlying: Common Stock · 3,564 shares

Expires 2034-05-13

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest on May 13, 2025, subject to continued service through the vesting date.

SEC source: 0000005513-23-000145 · wf-form4_168548711828820.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,054

F1 · shares: All are restricted stock units ("RSUs") vesting on May 25, 2024.

F2 · balance_after: Includes 8,287 RSUs and 25,767 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 5,395.118 RSUs since the date of the reporting person's prior Form 4.

SEC source: 0001156039-23-000068 · wf-form4_168392236656136.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,313

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0000005513-22-000110 · wf-form4_165403466808796.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,216

F1 · shares: All are restricted stock units ("RSUs") vesting on May 26, 2023.

F2 · balance_after: Includes 9,843 RSUs and 20,373 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 10,562.417 RSUs, and the exempt acquisitions of an aggregate of 225.118 RSUs pursuant to the reinvestment of dividends, since the date of the reporting person's prior Form 4.

SEC source: 0001156039-22-000068 · wf-form4_165307980598753.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 856

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-21-000082 · wf-form4_163070101226035.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416

F1 · shares: Phantom stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0000005513-21-000112 · wf-form4_162258764882823.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,543

F1 · shares: All are restricted stock units ("RSUs") vesting on May 27, 2022.

F2 · balance_after: Includes 15,732 RSUs and 9,810 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the exempt acquisitions of an aggregate of 512.417 RSUs pursuant to the reinvestment of dividends since the date of the reporting person's prior Form 4.

SEC source: 0001209191-20-048485 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 590,001

SEC source: 0001209191-20-048235 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,253

SEC source: 0000005513-20-000089 · wf-form4_159105614942092.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,860

F1 · shares: All are restricted stock units ("RSUs") vesting on May 28, 2021.

F2 · balance_after: Includes 10,050 RSUs and 9,810 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 9,059.909 RSUs, and the exempt acquisitions of an aggregate of 245.590 RSUs pursuant to the reinvestment of dividends, since the date of the reporting person's prior Form 4.

SEC source: 0001209191-19-048329 · doc4.xml · nonDerivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 526,198

SEC source: 0001209191-19-048329 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,627

SEC source: 0001209191-19-047518 · doc4.xml · nonDerivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,388

SEC source: 0001209191-19-047518 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 534,294

SEC source: 0000005513-19-000092 · wf-form4_155908102144106.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,565

F1 · shares: All are restricted stock units ("RSUs") vesting on May 23, 2020.

F2 · balance_after: Includes 8,814 RSUs and 750 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the delivery of shares of common stock upon the settlement of 750.309 RSUs, and the exempt acquisitions of an aggregate of 130.282 RSUs pursuant to the reinvestment of dividends, since the date of the reporting person's prior Form 4.

SEC source: 0001209191-18-049187 · doc4.xml · nonDerivative · entry 3

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440,869

SEC source: 0001209191-18-049187 · doc4.xml · nonDerivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,107

SEC source: 0001209191-18-049187 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,203

SEC source: 0001209191-18-048249 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,231

SEC source: 0001127602-18-019176 · form4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,626

F1 · shares: All are restricted stock units ("RSUs") vesting on May 24, 2019.

F2 · balance_after: All are RSUs which may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.

F3 · balance_after: Beneficial ownership amount accounts for the exempt acquisitions of an aggregate of 4.346 RSUs pursuant to the reinvestment of dividends since the date of the reporting person's prior Form 4.

SEC source: 0001209191-18-013871 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,176

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.34 to $32.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001127602-18-008538 · form4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 730

F1 · shares: All are restricted stock units ("RSUs") vesting on February 22, 2018. The RSUs may be settled, on a 1-for-1 basis, only in shares of common stock.

F1 · balance_after: All are restricted stock units ("RSUs") vesting on February 22, 2018. The RSUs may be settled, on a 1-for-1 basis, only in shares of common stock.

SEC source: 0001209191-17-050885 · doc4.xml · nonDerivative · entry 3

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,176

F1 · kind: The transaction reported on Line 3 of this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.59 to $32.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-050885 · doc4.xml · nonDerivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,176

SEC source: 0001209191-17-050885 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 466,427

SEC source: 0001209191-17-050384 · doc4.xml · derivative · entry 2

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,053

Underlying: Class A Common Stock · 77,053 shares

Expires 2027-08-25

F1 · derivative.exercise_date: The right to exercise one-third of the options on each of August 24, 2018, 2019 and 2020.

SEC source: 0001209191-17-050384 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 501,938

SEC source: 0001209191-17-048654 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,189

SEC source: 0001209191-17-039854 · doc4.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,589

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.88 to $35.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.